Cargando…
Muramyl Tripeptide Plus Chemotherapy Reduces Metastasis in Non-Metastatic Osteosarcoma: A Single-Center Experience
BACKGROUND: The immunomodulator mifamurtide plus a chemotherapy regimen has been shown to significantly improve the outcome in non-metastatic osteosarcoma patients. We report the results of the addition of mifamurtide to chemotherapy in newly diagnosed patients with osteosarcoma. METHODS: A total of...
Autores principales: | Taçyıldız, Nurdan, Ünal, Emel, Dinçaslan, Handan, Çakmak, H Mine, Köse, Kenan, Tanyıldız, Gülşah, Kartal, Ömer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437342/ https://www.ncbi.nlm.nih.gov/pubmed/32212798 http://dx.doi.org/10.31557/APJCP.2020.21.3.715 |
Ejemplares similares
-
Can Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Be Used As a Useful Method to Evaluate the Treatment Response to Neoadjuvant Therapy Combined With Sorafenib and Anti-VEGF in Children Diagnosed With Metastatical Bone Sarcoma?
por: Tacyildiz, Nurdan, et al.
Publicado: (2016) -
Rare childhood tumors in a Turkish pediatric oncology center
por: Tacyildiz, Nurdan, et al.
Publicado: (2013) -
The seroprevalence of Kaposi's sarcoma associated herpes virus and human herpes virus-6 in pediatric patients with cancer and healthy children in a Turkish pediatric oncology center
por: Tacyildiz, Nurdan, et al.
Publicado: (2014) -
Correction: A 20-year audit of retinoblastoma treatment outcomes
por: Gündüz, Ahmet Kaan, et al.
Publicado: (2020) -
A 20-year audit of retinoblastoma treatment outcomes
por: Gündüz, Ahmet Kaan, et al.
Publicado: (2020)